RETATRUTIDE 30MG

Advanced Triple-Receptor Research Peptide

Retatrutide is a next-generation metabolic research peptide designed to target GLP-1, GIP, and glucagon receptors simultaneously. Clinical research has generated significant interest in its effects on body composition and metabolic regulation.

Research Highlights

• Investigated for body weight reduction pathways
• Explored for appetite regulation mechanisms
• Studied for metabolic efficiency and energy expenditure
• Research interest in cardiometabolic health markers

Chemical Information

Molecular Formula: C₂₂₁H₃₄₂N₄₆O₆₈
Appearance: Lyophilised Powder
Purity: ≥98% (HPLC)
Storage: 2–8°C

For Research Purposes Only.
Not For Human Consumption.